Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.
Paik PK, Luo J, Ai N, Kim R, Ahn L, Biswas A, Coker C, Ma W, Wong P, Buonocore DJ, Lai WV, Chaft JE, Acharyya S, Massagué J, Kris MG.
Paik PK, et al. Among authors: kris mg.
Nat Commun. 2022 Oct 15;13(1):6095. doi: 10.1038/s41467-022-33719-6.
Nat Commun. 2022.
PMID: 36241629
Free PMC article.
Clinical Trial.